Brightlands Venture Partners logo

Brightlands Venture Partners

Europe, Limburg, The Netherlands, Geleen

Description

Brightlands Venture Partners (BVP) is an independent regional venture capital fund manager strategically located in Geleen, the Netherlands. The firm is deeply integrated into the innovative Brightlands ecosystems, which include campuses focused on materials, life sciences & health, sustainable food, and smart services. BVP's investment strategy is specifically tailored to support and accelerate companies that are active within these high-tech and knowledge-intensive domains, leveraging the region's robust infrastructure and collaborative environment.

BVP primarily targets early-stage and growth-stage companies, providing essential capital for their development and scaling. Their investment approach extends beyond mere financial backing, encompassing strategic guidance and facilitating access to their extensive network within the Brightlands community. The firm is recognized for its participation in seed and Series A rounds, often taking on roles as a lead or co-investor, demonstrating a commitment to fostering long-term partnerships with its portfolio companies.

Brightlands Venture Partners manages several specialized funds, including the Limburg Ventures, Brightlands Agrifood Fund, and Brightlands Smart Services Fund, collectively overseeing more than €100 million in capital. This substantial capital base enables them to support a diverse array of innovative ventures across their target sectors. To date, BVP has invested in over 35 companies, significantly contributing to the economic development and innovation landscape of the southern Netherlands. Their typical investments range from €0.5 million to €5 million per company, reflecting their capacity for impactful, substantial funding.

Investor Profile

Brightlands Venture Partners has backed more than 22 startups, with 3 new investments in the last 12 months alone. The firm has led 12 rounds, about 55% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in The Netherlands, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 1 rounds in the past year.
  • Typical check size: $540K – $5.4M.

Stage Focus

  • Seed (36%)
  • Series Unknown (27%)
  • Series A (23%)
  • Series B (9%)
  • Pre Seed (5%)

Country Focus

  • The Netherlands (86%)
  • Germany (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Food And Beverage
  • Product Management
  • Recycling
  • Life Science
  • Sustainability
  • Alternative Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Brightlands Venture Partners frequently co-invest with?

Avant Bio
North America, New York, United States, New York
Co-Investments: 1
better ventures
Europe, Bayern, Germany, München
Co-Investments: 1
NV Industriebank LIOF
Europe, Limburg, The Netherlands, Maastricht
Co-Investments: 6
AC
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 1
TechVision Fund
Europe, Nordrhein-Westfalen, Germany, Aachen
Co-Investments: 2
LePure Biotech
Asia, Shanghai, China, Shanghai
Co-Investments: 1
GOOSE Capital
North America, Texas, United States, Houston
Co-Investments: 1
b.value AG
Europe, Nordrhein-Westfalen, Germany, Dortmund
Co-Investments: 1
LI
Europe, Noord-Holland, The Netherlands, Heiloo
Co-Investments: 2
FG
Europe, Noord-Brabant, The Netherlands, Erp
Co-Investments: 2

Which angels does Brightlands Venture Partners often collaborate with?

YG
Europe, Berlin, Germany, Berlin
Shared Deals: 1

What are some of recent deals done by Brightlands Venture Partners?

Novenda Technologies

Geleen, Limburg, The Netherlands

Novenda Technologies provides multi-material 3D printing solutions for dental and medical technology applications using material jetting.

3D PrintingGraphic DesignPrinting
Series AJul 9, 2025
Amount Raised: $6,100,000
Hy2Care

Enschede, Overijssel, The Netherlands

Hy2Care BV develops a novel technology platform consisting of injectable hydrogels to fight osteoarthritis

Health CareMedicalMedical Device
Series UnknownMay 14, 2025
Amount Raised: $5,031,323
Grassa

Grubbenvorst, Limburg, The Netherlands

GRASSA! wil dat de wereld overgaat op een duurzamer voedingsconcept

Animal FeedDairyFood and Beverage
Series UnknownMar 19, 2025
Amount Raised: $3,928,236
PL BioScience

Aachen, Nordrhein-Westfalen, Germany

We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate

BiotechnologyHealth Care
Series AAug 8, 2024
Amount Raised: $8,513,704
Vivalyx

Aachen, Nordrhein-Westfalen, Germany

Vivalyx is committed to saving the lives of organ failure patients by boosting the vitality and number of donor organs.

Health CareManufacturingMedical
SeedApr 30, 2024
Amount Raised: $5,759,681
Qorium

Maastricht, Limburg, The Netherlands

Real Leather, Reinvented

Biotechnology
SeedJan 10, 2024
Matisse Pharmaceuticals

Geleen, Limburg, The Netherlands

Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies.

BiopharmaBiotechnologyLife Science
Series UnknownJan 4, 2024
Amount Raised: $3,941,098
Corporis Medical

Maastricht, Limburg, The Netherlands

Corporis Medical is a developer and commercialiser of innovative medical devices.

CommercialMedicalMedical Device
Series BDec 7, 2023
Amount Raised: $4,315,921
ReSolved Technologies

Sittard, Limburg, The Netherlands

ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams.

RecyclingWaste Management
SeedAug 30, 2023
Amount Raised: $1,092,952
Circularise

The Hague, Zuid-Holland, The Netherlands

Circularise provides digital product passport and mass balance bookkeeping software for secure data exchange for industrial supply chains

CleanTechProduct ManagementSaaSSupply Chain ManagementSustainability
Series ANov 17, 2022
Amount Raised: $11,397,275